Orniplabin Impurity 1 - Request Quote
Orniplabin Impurity 1
| SZ CAT No: | SZ-O084002 |
| CAS No | NA |
| Mol.F. | C51H68N2O10 |
| Mol.Wt. |
869.1 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Orniplabin Impurity 1 is chemically (S)-2-((2R,3S)-2-((E)-4,8-dimethylnona-3,7-dien-1-yl)-3,5-dihydroxy-2-methyl-7-oxo-3,4,7,9-tetrahydropyrano[2,3-e]isoindol-8(2H)-yl)-5-((2S,3R)-2-((E)-4,8-dimethylnona-3,7-dien-1-yl)-3,5-dihydroxy-2-methyl-7-oxo-3,4,7,9-tetrahydropyrano[2,3-e]isoindol-8(2H)-yl)pentanoic acid. Orniplabin Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Orniplabin Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Orniplabin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Orniplabin Impurity 1
Purchase Orniplabin Impurity 1
Orniplabin Impurity 1 suppliers
Orniplabin Impurity 1 manufacturers
Orniplabin Impurity 1 price
Order Orniplabin Impurity 1
Enquire Orniplabin Impurity 1
Orniplabin Impurity 1 cost
Orniplabin Impurity 1 Supplier
Orniplabin Impurity 1 Distributor
Orniplabin Impurity 1 for Method Validation
Orniplabin Reference Standard
Orniplabin Impurity 1 for ANDA Filing
Orniplabin Impurity 1 for Forced Degradation Studies
Orniplabin Impurity 1 Identification Standards
Orniplabin Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.